Advos

HeartBeam (NASDAQ: BEAT) announced its first-quarter 2026 financial results, highlighting commercial partnerships in key U.S. markets and an $11.5 million public offering, as it progresses toward launching its FDA-cleared 3D ECG technology for heart attack detection and ambulatory monitoring.

BOXABL and FG Merger II Corp. announced SEC effectiveness of their Form S-4, paving the way for BOXABL to become a publicly traded company on Nasdaq under ticker BXBL.

BluSky AI Inc. outlines its SkyMod modular data center strategy to address accelerating demand for high-performance AI compute infrastructure.

American Fusion Inc. has finished the structural frame for its 5MW Texatron pre-production system, signaling a shift to integrated assembly and testing as it advances modular fusion energy development.

Dogwood Therapeutics announced first quarter 2026 financial results, with key pipeline milestones including Phase 2b data for Halneuron® expected this fall and FDA clearance for SP16 to enter Phase 1b, while maintaining cash runway into Q4 2026.

Crypto asset investment products saw nearly $860 million in inflows last week, driven by optimism over proposed U.S. regulation, marking six consecutive weeks of positive flows.

Microsoft is considering delaying or scrapping its 2030 hourly clean energy matching target due to surging power demand from AI, highlighting the tension between climate commitments and technology growth.

The ongoing crisis in the Strait of Hormuz is disrupting shipments of raw materials essential for EV battery production, risking supply shortages and higher costs for manufacturers like Rivian Automotive Inc.

The Department of Health and Human Services proposes easing safeguards for AI healthcare tools, removing real-world testing requirements, drawing mixed reactions from stakeholders.

LIG Assets, Inc. is working on a technical report to update the valuation of its calcium carbonate mine, which was previously appraised at $400 million in 2009, amid rising market prices and demand.

BluSky AI Inc. has initiated a Regulation A+ offering to raise capital for expanding its distributed AI infrastructure network, allowing both individual and accredited investors to participate with a minimum investment of $1,000.

Aditxt Inc. will execute a 1-for-27 reverse stock split on May 18 to meet Nasdaq's minimum bid price requirement, reducing outstanding shares from 13.8 million to about 510,123.

SPARC AI Inc. was featured in an AINewsWire editorial examining autonomous warfare technologies, highlighting its software-only platform that enables drones to navigate and target without GPS in contested electronic warfare environments.

MindBio Therapeutics Corp. was featured in a BioMedWire editorial discussing its AI-driven voice analysis platform for real-time intoxication detection, addressing growing demand across healthcare, workplace safety, and public health.

CNS Pharmaceuticals reported first-quarter 2026 financial results, highlighting progress in its shift to an acquisition-driven growth model, bolstered by a $22.5 million private placement to support operations beyond 12 months.

Kairos Pharma receives the 2026 GHP Magazine Healthcare & Pharmaceutical Award for its innovative work in developing cancer therapeutics that target drug resistance.

SureNano Science Ltd. announced its placement in a BioMedWire editorial highlighting its subsidiary GlucaPharm's novel triple agonist peptide GEP-44 for obesity and diabetes, underscoring potential advances in GLP-1 therapeutics.

NextPlat Corp announced improved first-quarter 2026 results with record gross margins and reduced losses, signaling progress in its turnaround strategy.